Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

IPSEN BIOPHARMACEUTICALS INC

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 39
  • 0 comments

FDA approve PALOVAROTENE

Comment Full text

UCB INC

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 37
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 39
  • 0 comments

FDA approve CHLORZOXAZONE

Comment Full text

UCB INC

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 44
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

PHATHOM

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 35
  • 0 comments

FDA approve AMOXICILLIN; VONOPRAZAN FUMARATE

Comment Full text

AVET LIFESCIENCES

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 43
  • 0 comments

FDA approve PROPOFOL

Comment Full text

PFIZER INC

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 42
  • 0 comments

FDA approve ADALIMUMAB-AFZB

Comment Full text

DR REDDYS

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 37
  • 0 comments

FDA approve IMATINIB MESYLATE

Comment Full text

SUNSHINE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 34
  • 0 comments

FDA approve CLARITHROMYCIN

Comment Full text

AMNEAL

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 42
  • 0 comments

FDA approve DOXEPIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 708
  • 709
  • 710
  • 711
  • 712
  • Next

Search

News categories

  • Technical Exchange News(14740)
  • Event(6229)
  • SEC News(396208)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(241569)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin